Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-25-000136
Filing Date
2025-05-14
Accepted
2025-05-14 14:19:17
Documents
50
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skvi10q1_033125.htm   iXBRL 10-Q 421538
2 GRAPHIC image_001.jpg GRAPHIC 8053
3 GRAPHIC image_002.jpg GRAPHIC 8465
9 CERTIFICATION ex31_1.htm EX-31.1 9097
10 CERTIFICATION ex31_2.htm EX-31.2 9017
11 CERTIFICATION ex32_1.htm EX-32.1 4149
  Complete submission text file 0001663577-25-000136.txt   2477894

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE skvi-20250331.xsd EX-101.SCH 20697
5 XBRL CALCULATION FILE skvi-20250331_cal.xml EX-101.CAL 34581
6 XBRL DEFINITION FILE skvi-20250331_def.xml EX-101.DEF 57327
7 XBRL LABEL FILE skvi-20250331_lab.xml EX-101.LAB 153976
8 XBRL PRESENTATION FILE skvi-20250331_pre.xml EX-101.PRE 133426
53 EXTRACTED XBRL INSTANCE DOCUMENT skvi10q1_033125_htm.xml XML 210193
Mailing Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120 702-433-7154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

EIN.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25911 | Film No.: 25944509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)